Valuation: EirGenix Inc.

Market Cap 15.05B 472M 412M 378M 353M 669M 44.89B 680M 4.54B 1.77B 22.03B 1.77B 1.73B 76.08B P/E 2024
-31.6x
P/E 2025 -24.5x
Enterprise Value 13.23B 415M 362M 332M 310M 588M 39.46B 598M 3.99B 1.55B 19.37B 1.56B 1.52B 66.88B EV / Sales 2024
18.2x
EV / Sales 2025 16.8x
Free-Float
60%
Yield 2024 *
-
Yield 2025 -
1 day+5.97%
1 week+7.81%
Current month-0.40%
1 month+10.94%
3 months-13.26%
6 months-19.97%
Current year-19.45%
1 week 46.3
Extreme 46.3
53
1 month 40.2
Extreme 40.2
53
Current year 40.15
Extreme 40.15
67.6
1 year 40.15
Extreme 40.15
84.3
3 years 40.15
Extreme 40.15
112
5 years 40.15
Extreme 40.15
163.5
10 years 21.55
Extreme 21.55
195
Manager TitleAgeSince
Chief Executive Officer - 01/04/2013
Director of Finance/CFO - 03/05/2016
Corporate Officer/Principal - 20/05/2019
Director TitleAgeSince
Director/Board Member - 14/06/2013
Director/Board Member - 13/09/2016
Chairman - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+5.97%+7.81%-22.34%-55.02% 471M
+4.73%+3.38%+19.53%-8.89% 66.56B
-1.93%+0.39%+58.62%+226.33% 56.51B
+1.07%+42.10%+42.10%+42.10% 42.98B
+3.45%+6.04%-49.46%-55.91% 40.46B
+3.04%+0.04%+62.66%-24.29% 31.91B
+10.01%+18.57%+161.59%-34.48% 31.65B
+2.68%+2.73%+70.72%+88.24% 23.35B
+2.87%+16.83%+3.78%+192.67% 19.46B
-0.13%+2.75%+67.48%+130.07% 17.18B
Average +3.18%+8.19%+41.47%+50.08% 33.05B
Weighted average by Cap. +2.80%+7.31%+43.59%+54.15%

Financials

2024 2025
Net sales 1.01B 31.61M 27.6M 25.35M 23.64M 44.84M 3.01B 45.59M 305M 118M 1.48B 119M 116M 5.1B 1.01B 31.49M 27.5M 25.25M 23.55M 44.67M 3B 45.42M 303M 118M 1.47B 118M 116M 5.08B
Net income -698M -21.88M -19.11M -17.54M -16.36M -31.03M -2.08B -31.55M -211M -81.9M -1.02B -82.13M -80.34M -3.53B -761M -23.82M -20.81M -19.11M -17.82M -33.8M -2.27B -34.36M -230M -89.2M -1.11B -89.45M -87.5M -3.84B
Net Debt -3.7B -116M -101M -92.86M -86.62M -164M -11.02B -167M -1.12B -434M -5.41B -435M -425M -18.68B -1.82B -57.01M -49.79M -45.72M -42.65M -80.88M -5.43B -82.23M -549M -213M -2.66B -214M -209M -9.2B
Logo EirGenix Inc.
EirGenix Inc is a Taiwan-based company primarily engaged in the development of antibody drugs and the manufacture of biopharmaceuticals. Its main businesses include the provision of Contract Development & Manufacturing Organization (CDMO) services, the construction of cell strain, the manufacture of clinical trial medicine, analytical science and protein identification, and PIC/S manufacturing plant to provide clinical trial drug production.
Employees
1,000
Date Price Change Volume
03/07/26 NT$49.70 +5.97% 1,611,002
02/07/26 NT$46.90 -3.30% 1,404,591
01/07/26 NT$48.50 -2.81% 2,793,045
30/06/26 NT$49.90 +3.53% 1,972,586
29/06/26 NT$48.20 +4.56% 1,520,190
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6589 Stock